Genetics of metabolic syndrome

Current Diabetes Reports

Volumn 8, Issue 2, 2008, Pages 141-148

  Joy, Tisha ^b   Lahiry, Piya ^b   Pollex, Rebecca L ^b   Hegele, Robert A ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ADIPONECTIN; ALDOSTERONE SYNTHASE; APOLIPOPROTEIN A5; APOLIPOPROTEIN C3; AUTOTAXIN; BETA 3 ADRENERGIC RECEPTOR; COMPLEMENT COMPONENT C1Q; CYTOCHROME P450 3A4; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN RECEPTOR ALPHA; GHRELIN; GLUCOSE; INTERLEUKIN 6; LAMIN A; LAMIN C; LIPID; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN RECEPTOR; MITOCHONDRIAL DNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESISTIN; SEROTONIN 2C RECEPTOR; TUMOR NECROSIS FACTOR; UNCOUPLING PROTEIN 2; APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A; TRISTETRAPROLIN; ZFP36 PROTEIN, HUMAN;

ABDOMINAL OBESITY; CARDIOVASCULAR DISEASE; CHROMOSOME 17P; CHROMOSOME 1Q; CHROMOSOME 3Q; CHROMOSOME 6; CHROMOSOME 7; CLINICAL FEATURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENVIRONMENTAL FACTOR; GENE CLUSTER; GENETIC ANALYSIS; GENETIC ASSOCIATION; HEREDITY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LINKAGE ANALYSIS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PHENOTYPE; POPULATION GENETICS; QUANTITATIVE TRAIT LOCUS; REVIEW; UNITED STATES; ADIPOSE TISSUE; ANIMAL; ENERGY METABOLISM; GENETIC LINKAGE; GENETICS; METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPOSE TISSUE; ANIMALS; APOLIPOPROTEINS A; ENERGY METABOLISM; GLUCOSE; HUMANS; LINKAGE (GENETICS); METABOLIC SYNDROME X; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; TRISTETRAPROLIN;

EID: 44849141754     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-008-0025-y     Document Type: Review

References (78)

1. WHO: Definition, diagnosis, and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Available at http://www.staff.newcastle.ac.uk/philip.home/who_dmc.htm. Accessed December 6, 2007.
2. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) [no authors listed]. JAMA 2001, 285:2486-2497.
3. Alberti KG, Zimmet P, Shaw J: The metabolic syndrome - a new worldwide definition. Lancet 2005, 366:109-1062.
4. Balkau B, Charles MA: Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999, 16:442-443.
5. Einhorn D, Reaven GM, Cobin RH, et al.: American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003, 9:237-252.
6. Grundy SM, Cleeman JI, Daniels SR, et al.: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
7. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
8. Carmelli D, Cardon LR, Fabsitz R: Clustering of hypertension, diabetes, and obesity in adult male twins: same genes or same environments? Am J Hum Genet 1994, 55:566-573.
9. Edwards KL, Newman B, Mayer E, et al.: Heritability of factors of the insulin resistance syndrome in women twins. Genet Epidemiol 1997, 14:241-253.
10. Lin HF, Boden-Albala B, Juo SH, et al.: Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study. Diabetologia 2005, 48:2006-2012.
11. Kissebah AH, Sonnenberg GE, Myklebust J, et al.: Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A 2000, 97:14478-14483.
12. Arya R, Blangero J, Williams K, et al.: Factors of insulin resistance syndrome - related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic Mexican-Americans. Diabetes 2002, 51:841-847.
13. Langefeld CD, Wagenknecht LE, Rotter JI, et al.: Linkage of the metabolic syndrome to 1q23-q31 in Hispanic families: the Insulin Resistance Atherosclerosis Study Family Study. Diabetes 2004, 53:1170-1174.
14. Loos RJ, Katzmarzyk PT, Rao DC, et al.: Genome-wide linkage scan for the metabolic syndrome in the HERITAGE Family Study. J Clin Endocrinol Metab 2003, 88:5935-5943.
15. Hsueh WC, St Jean PL, Mitchell BD, et al.: Genome-wide and fine-mapping linkage studies of type 2 diabetes and glucose traits in the Old Order Amish: evidence for a new diabetes locus on chromosome 14q11 and confirmation of a locus on chromosome 1q21-q24. Diabetes 2003, 52:550-557.
16. Ng MC, So WY, Cox NJ, et al.: Genome-wide scan for type 2 diabetes loci in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-q25. Diabetes 2004, 53:1609-1613.
17. Das SK, Hasstedt SJ, Zhang Z, Elbein SC: Linkage and association mapping of a chromosome 1q21-q24 type 2 diabetes susceptibility locus in northern European Caucasians. Diabetes 2004, 53:492-499.
18. Vionnet N, Hani EH, Dupont S, et al.: Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 2000, 67:1470-1480.
19. Thameem F, Farook VS, Bogardus C, Prochazka M: Association of amino acid variants in the activating transcription factor 6 gene (ATF6) on 1q21-q23 with type 2 diabetes in Pima Indians. Diabetes 2006, 55:839-842.
20. Ng MC, So WY, Lam VK, et al.: Genome-wide scan for metabolic syndrome and related quantitative traits in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-q25. Diabetes 2004, 53:2676-2683.
21. Hoffmann K, Mattheisen M, Dahm S, et al.: A German genome-wide linkage scan for type 2 diabetes supports the existence of a metabolic syndrome locus on chromosome 1p36.13 and a type 2 diabetes locus on chromosome 16p12.2. Diabetologia 2007, 50:1418-1422.
22. Bowden DW, Rudock M, Ziegler J, et al.: Coincident linkage of type 2 diabetes, metabolic syndrome, and measures of cardiovascular disease in a genome scan of the diabetes heart study. Diabetes 2006, 55:1985-1994.
23. Yang WS, Yang YC, Chen CL, et al.: Adiponectin SNP276 is associated with obesity, the metabolic syndrome, and diabetes in the elderly. Am J Clin Nutr 2007, 86:509-513.
24. Norata GD, Ongari M, Garlaschelli K, et al.: Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction. J Intern Med 2007, 262:104-112.
25. Mousavinasab F, Tahtinen T, Jokelainen J, et al.: The Pro-12Ala polymorphism of the PPAR gamma 2 gene influences sex hormone-binding globulin level and its relationship to the development of the metabolic syndrome in young Finnish men. Endocrine 2006, 30:185-190.
26. Rhee EJ, Oh KW, Lee WY, et al.: Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome. Arch Med Res 2006, 37:86-94.
27. Tonjes A, Scholz M, Loeffler M, Stumvoll M: Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals. Diabetes Care 2006, 29:2489-2497.
28. Meirhaeghe A, Cottel D, Amouyel P, Dallongeville J: Association between peroxisome proliferator-activated receptor gamma haplotypes and the metabolic syndrome in French men and women. Diabetes 2005, 54:3043-3048.
29. Robitaille J, Brouillette C, Houde A, et al.: Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome. J Hum Genet 2004, 49:482-489.
30. Robitaille J, Gaudet D, Perusse L, Vohl MC: Features of the metabolic syndrome are modulated by an interaction between the peroxisome proliferator-activated receptor-delta -87T>C polymorphism. and dietary fat in French-Canadians. Int J Obes (Lond) 2007, 31:411-417.
31. Miller M, Rhyne J, Chen H, et al.: APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome. Arch Med Res 2007, 38:444-451.
32. Pennacchio LA, Olivier M, Hubacek JA, et al.: An apolipoprotcin influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001, 294:169-173.
33. Yamada Y, Kato K, Hibino T, et al.: Prediction of genetic risk for metabolic syndrome. Atherosclerosis 2007, 191:298-304.
34. Grallert H, Sedlmeier EM, Huth C, et al.: APOAS variants and metabolic syndrome in Caucasians. J Lipid Res 2007, 48:2614-2621.
35. Komurcu-Bayrak E, Onat A, Poda M, et al.: The S447X variant of lipoprotein lipase gene is associated with metabolic syndrome and lipid levels among Turks. Clin Chim Acta 2007, 383:110-115.
36. Hamid YH, Rose CS, Urhammer SA, et al.: Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia 2005, 48:251-260.
37. Stephens JW, Hurel SJ, Lowe GD, et al.: Association between plasma IL-6, the 116 -174G>C gene variant and the metabolic syndrome in type 2 diabetes mellitus. Mol Genet Metab 2007, 90:422-428.
38. Sedlmeier EM, Grallert H, Huth C, et al.: Gene variants of monocyte chemoattractant protein 1 and components of metabolic syndrome in KORA S4, Augsburg. Eur J Endocrinol 2007, 156:377-385.
39. Sookoian SC, Gonzalez C, Pirola CJ: Meta-analysis on the G-308A tumor necrosis factor alpha gene variant and phenotypes associated with the metabolic syndrome. Obes Res 2005, 13:2122-2131.
40. Carballo E, Lai WS, Blackshear PJ: Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 1998, 281:1001-1005.
41. Bouchard L, Tchernof A, Deshaies Y, et al.: ZFP36: a promising candidate gene for obesity-related metabolic complications identified by converging genomics. Obes Surg 2007, 17:372-382.
42. Bosse Y, Despres JP, Chagnon YC, et al.: Quantitative trait locus on 15q for a metabolic syndrome variable derived from factor analysis. Obesity (Silver Spring) 2007, 15:544-550.
43. Hegele RA, Anderson CM, Wang J, et al.: Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dystipidemia, hypertension, and diabetes. Genome Res 2000, 10:652-658.
44. Cao H, Hegele RA: Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 2000, 9:109-112.
45. Shackleton S, Lloyd DJ, Jackson SN, et al.: LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet 2000, 24:153-156.
46. Mesa JL, Loos RJ, Franks PW, et al.: Lamin A/C polymorphisms, type 2 diabetes, and the metabolic syndrome: case-control and quantitative trait studies. Diabetes 2007, 56:884-889.
47. Robitaille J, Brouillette C, Houde A, et al.: Molecular screening of the 11beta-HSD1 gene in men characterized by the metabolic syndrome. Obes Res 2004, 12:1570-1575.
48. Seckl JR, Morton NM, Chapman KE, Walker BR: Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue. Recent Prog Horm Res 2004, 59:359-393.
49. Oakley RH, Jewell CM, Yudt MR, et al.: The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. J Biol Cbem 1999, 274:27857-27866.
50. Derijk RH, Schaaf MJ, Turner G, et al.: A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis. J Rheumatol 2001, 28:2383-2388.
51. Syed AA, Irving JA, Redfern CP, et al.: Association of glucocorticoid receptor polymorphism A3669G in exon 9beta with reduced central adiposity in women. Obesity (Silver Spring) 2006, 14:759-764.
52. Gallagher CJ, Langefeld CD, Gordon CJ, et al.: Association of the estrogen receptor-alpha gene with the metabolic syndrome and its component traits in African-American families: the Insulin Resistance Atherosclerosis Family Study. Diabetes 2007, 56:2135-2141.
53. Dong H, Maddux BA, Altomonte J, et al.: Increased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intolerance. Diabetes 2005, 54:367-372.
54. Tasic I, Milojkovic M, Sunder-Plassmann R, et al.: The association of PC-1 (ENPP1) K121Q polymorphism with metabolic syndrome in patients with coronary heart disease. Clin Chim Acta 2007, 377:237-242.
55. Higaki Y, Hirshman MF, Fujii N, Goodyear LJ: Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. Diabetes 2001, 50:241-247.
56. Pieper GM: Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetologia 1999, 42:204-213.
57. Gonzalez-Sanchez JL, Martinez-Larrad MT, Saez ME, et al.: Endothelial nitric oxide synthase haplotypes; are associated with features of metabolic syndrome. Clin Chem 2007, 53:91-97.
58. Krief S, Lonnqvist F, Raimbault S, et al.: Tissue distribution of beta 3-adrenergic receptor mRNA in man. J Clin Invest 1993, 91:344-349.
59. Emorine LJ, Marullo S, Briend-Sutren MM, et al.: Molecular characterization of the human beta 3-adrenergic receptor. Science 1989, 245:1118-1121.
60. Tamaki S, Nakamura Y, Tabara Y, et al.: Relationship between metabolic syndrome and Trp64arg polymorphism of the beta-adrenergic receptor gene in a general sample: the Shigaraki study. Hypertens Res 2006, 29:891-896.
61. Fleury C, Neverova M, Collins S, et al.: Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 1997, 15:269-272.
62. Chan CB, Saleh MC, Koshkin V, Wheeler MB: Uncoupling protein 2 and islet function. Diabetes 2004, 53(Suppl 1): S136-S142.
63. Himms-Hagen J, Harper ME: Physiological role of UCP3 may be export of fatty acids from mitochondria when fatty acid oxidation predominates: an hypothesis. Exp Biol Med 2001, 226:78-84.
64. Shen H, Qi L, Tai ES, et al.: Uncoupling protein 2 promoter polymorphism -866G/A, central adiposity, and metabolic syndrome in Asians. Obesity (Silver Spring) 2006, 14:656-661.
65. Wang H, Chu WS, Lu T, et al.. Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion. Am J Physiol 2004, 286:E1-E7.
66. Yamada Y, Ichihara S, Kato K, et al.: Genetic risk for metabolic syndrome: examination of candidate gene polymorphisms related to tipid metabolism in Japanese individuals. J Med Genet 2008, 45:22-28.
67. Shapiro L, Scherer PE: The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol 1998, 8:335-338.
68. Lee YH, Nair S, Rousseau E, et al.: Microarray profiting of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes. Diabetologia 2005, 48:1776-1783.
69. McCarthy JJ, Meyer J, Moliterno DJ, et al.: Evidence for substantial effect modification by gender in a Luge-scale genetic association study of the metabolic syndrome among coronary heart disease patients. Hum Genet 2003, 114:87-98.
70. Russo P, Lauria F, Loguercio M, et al.: -344C/T Variant in the promoter of the aldosterone synthase gene (CYP11B2) is associated with metabolic syndrome in men. Am J Hypertens 2007, 20:218-222.
71. Tanaka M, Fuku N, Nishigaki Y, et al.: Women with mitochondrial haplogroup N9a are protected against metabolic syndrome. Diabetes 2007, 56:518-521.
72. Wang B, Chehab FF: Deletion of the serotonin 2c receptor from transgenic mice overexpressing leptin does not affect their lipodystrophy but exacerbates their diet-induced obesity. Biochem Biopbys Res Comm 2006, 351:418-423.
73. Mulder H, Franke B, van der-Beek van der AA, et al.: The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia. J Clin Psychopharmacol 2007, 27:338-343.
74. Frayling TM, Timpson NJ, Weedon MN, et al.: A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316:889-894.
75. Dina C, Meyre D, Gallina S, et al.: Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 2007, 39:724-726.
76. Lyon HN, Emilsson V, Hinney A, et al.: The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts. PLoS Genet 2007, 3:e61.
77. Pollex RL, Hanley AJ, Zinman B, et al.: Metabolic syndrome in aboriginal Canadians: prevalence and genetic associations. Atherosclerosis 2006, 184:121-129.
78. Lahiry P, Pollex RL, Hegele RA: Uncloaking the genetic determinants of metabolic syndrome. Nutrigenetics Nutrigenomics 2008, in press.